Home
Conditions
Bile Duct Neoplasms

Clinical trial condition

Bile Duct Neoplasms

Explore clinical trials studying Bile Duct Neoplasms. Study availability and eligibility vary by location and protocol.

169 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Bile Duct Neoplasms trial results

Not yet recruiting

Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)

NCT07558304

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +11 more
Locations: Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Not yet recruiting

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

NCT07036185

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

NCT06730581

Conditions: Adnexal Diseases, Bile Duct Cancer, Bile Duct Diseases, +25 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases

NCT05896956

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +22 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma

NCT06076252

Conditions: Ampullary Cancer, Bile Duct Cancer, Bile Duct Diseases, +19 more
Locations: The Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China

View Trial Details

Active, not recruiting

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

NCT02293954

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +59 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents

NCT06453590

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +20 more
Locations: Danderyds hospital Danderyd, Sweden

Sahlgrenska University hospital Gothenburg, Sweden

Central Hospital Karlstad Karlstad, Sweden

University Hospital Lund Lund, Sweden

View Trial Details

Active, not recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations: Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Michigan Health System Ann Arbor, Michigan, United States

Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Active, not recruiting

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

NCT05277766

Conditions: Abdominal Neoplasms, Adenocarcinoma, Appendiceal Neoplasms, +37 more
Locations: UZ Ghent Ghent, East-Flanders, Belgium

View Trial Details

Active, not recruiting

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

NCT06109779

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Phoenix, Arizona, United States

Research Site Los Angeles, California, United States

Research Site Orange, California, United States

View all 177 locations

View Trial Details

Bile Duct Neoplasms

Bile Duct Neoplasms trial results

Related conditions